Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma

Fig. 3

Representative profiles of cell-cycle progression. MSTO-211H (a) or NCI-H28 cells (b) were treated with ZOL (MSTO-211H: 10 μM; NCI-H28: 80 μM) and/or either Ad-delE1B55 or Ad-LacZ (MSTO-211H: 4.5 × 103 vp/cell; NCI-H226: 2 × 103 vp/cell). The cell cycle progression was analyzed with flow cytometry at 24, 48 and 72 h after the treatments

Back to article page